These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26700834)

  • 1. Complete Versus Lesion-Only Primary PCI: The Randomized Cardiovascular MR CvLPRIT Substudy.
    McCann GP; Khan JN; Greenwood JP; Nazir S; Dalby M; Curzen N; Hetherington S; Kelly DJ; Blackman DJ; Ring A; Peebles C; Wong J; Sasikaran T; Flather M; Swanton H; Gershlick AH
    J Am Coll Cardiol; 2015 Dec; 66(24):2713-2724. PubMed ID: 26700834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infarct size following complete revascularization in patients presenting with STEMI: a comparison of immediate and staged in-hospital non-infarct related artery PCI subgroups in the CvLPRIT study.
    Khan JN; Nazir SA; Greenwood JP; Dalby M; Curzen N; Hetherington S; Kelly DJ; Blackman D; Ring A; Peebles C; Wong J; Sasikaran T; Flather M; Swanton H; Gershlick AH; McCann GP
    J Cardiovasc Magn Reson; 2016 Nov; 18(1):85. PubMed ID: 27842548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial.
    Gershlick AH; Khan JN; Kelly DJ; Greenwood JP; Sasikaran T; Curzen N; Blackman DJ; Dalby M; Fairbrother KL; Banya W; Wang D; Flather M; Hetherington SL; Kelion AD; Talwar S; Gunning M; Hall R; Swanton H; McCann GP
    J Am Coll Cardiol; 2015 Mar; 65(10):963-72. PubMed ID: 25766941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infarct Size Following Treatment With Second- Versus Third-Generation P2Y12 Antagonists in Patients With Multivessel Coronary Disease at ST-Segment Elevation Myocardial Infarction in the CvLPRIT Study.
    Khan JN; Greenwood JP; Nazir SA; Lai FY; Dalby M; Curzen N; Hetherington S; Kelly DJ; Blackman D; Peebles C; Wong J; Flather M; Swanton H; Gershlick AH; McCann GP
    J Am Heart Assoc; 2016 May; 5(6):. PubMed ID: 27247336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Long-Term Clinical Outcome Between Multivessel Percutaneous Coronary Intervention Versus Infarct-Related Artery-Only Revascularization for Patients With ST-Segment-Elevation Myocardial Infarction With Cardiogenic Shock.
    Lee JM; Rhee TM; Kim HK; Hwang D; Lee SH; Choi KH; Kim J; Park TK; Yang JH; Song YB; Choi JH; Choi SH; Koo BK; Chae SC; Cho MC; Kim CJ; Kim JH; Kim HS; Gwon HC; Jeong MH; Hahn JY;
    J Am Heart Assoc; 2019 Dec; 8(24):e013870. PubMed ID: 31818215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and design.
    Kelly DJ; McCann GP; Blackman D; Curzen NP; Dalby M; Greenwood JP; Fairbrother K; Shipley L; Kelion A; Heatherington S; Khan JN; Nazir S; Alahmar A; Flather M; Swanton H; Schofield P; Gunning M; Hall R; Gershlick AH
    EuroIntervention; 2013 Feb; 8(10):1190-8. PubMed ID: 23425543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.
    Kyhl K; Ahtarovski KA; Nepper-Christensen L; Ekström K; Ghotbi AA; Schoos M; Göransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Høfsten DE; Køber L; Kelbæk H; Vejlstrup N; Lønborg J; Engstrøm T
    JACC Cardiovasc Interv; 2019 Apr; 12(8):721-730. PubMed ID: 31000010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock.
    Lee JM; Rhee TM; Hahn JY; Kim HK; Park J; Hwang D; Choi KH; Kim J; Park TK; Yang JH; Song YB; Choi JH; Choi SH; Koo BK; Kim YJ; Chae SC; Cho MC; Kim CJ; Gwon HC; Kim JH; Kim HS; Jeong MH;
    J Am Coll Cardiol; 2018 Feb; 71(8):844-856. PubMed ID: 29471935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-infarct-related artery revascularization during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis.
    Bagai A; Thavendiranathan P; Sharieff W; Al Lawati HA; Cheema AN
    Am Heart J; 2013 Oct; 166(4):684-693.e1. PubMed ID: 24093848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial.
    Kim MC; Ahn JH; Hyun DY; Lim Y; Lee SH; Oh S; Cho KH; Sim DS; Hong YJ; Kim JH; Jeong MH; Cho JH; Lee SR; Kang DO; Hwang JY; Youn YJ; Jeong YH; Park Y; Kim DB; Choo EH; Kim CJ; Kim W; Rhew JY; Lee JH; Yoo SY; Ahn Y;
    Am Heart J; 2024 Jul; 273():35-43. PubMed ID: 38641031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Follow-Up of Complete Versus Lesion-Only Revascularization in STEMI and Multivessel Disease: The CvLPRIT Trial.
    Gershlick AH; Banning AS; Parker E; Wang D; Budgeon CA; Kelly DJ; Kane PO; Dalby M; Hetherington SL; McCann GP; Greenwood JP; Curzen N
    J Am Coll Cardiol; 2019 Dec; 74(25):3083-3094. PubMed ID: 31856964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial.
    Wood DA; Cairns JA; Wang J; Mehran R; Storey RF; Nguyen H; Meeks B; Kunadian V; Tanguay JF; Kim HH; Cheema A; Dehghani P; Natarajan MK; Jolly SS; Amerena J; Keltai M; James S; Hlinomaz O; Niemela K; AlHabib K; Lewis BS; Nguyen M; Sarma J; Dzavik V; Della Siega A; Mehta SR;
    J Am Coll Cardiol; 2019 Dec; 74(22):2713-2723. PubMed ID: 31779786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.
    Engstrøm T; Kelbæk H; Helqvist S; Høfsten DE; Kløvgaard L; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L;
    Lancet; 2015 Aug; 386(9994):665-71. PubMed ID: 26347918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary angiography- or fractional flow reserve-guided complete revascularization in multivessel disease STEMI: A Bayesian hierarchical network meta-analysis.
    Archilletti F; Ricci F; Pelliccia F; Dangas G; Giuliani L; Radico F; Perfetti M; Rossi S; Gallina S; Maddestra N; Khanji MY; Zimarino M
    Int J Cardiol; 2023 Jan; 370():122-128. PubMed ID: 36328114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 30-day mortality and myocardial scar indices for patients treated with prehospital reduced dose fibrinolytic followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction.
    Solhpour A; Chang KW; Arain SA; Balan P; Zhao Y; Loghin C; McCarthy JJ; Vernon Anderson H; Smalling RW
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):709-715. PubMed ID: 27028120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of fractional flow reserve guided complete revascularization versus infarct related artery only revascularization in patients with ST-elevation myocardial infarction and multivessel coronary artery disease.
    Neupane S; Singh H; Edla S; Altujjar M; Yamsaki H; Lalonde T; Rosman HS; Eggebrecht H; Mehta RH
    Coron Artery Dis; 2019 Sep; 30(6):393-397. PubMed ID: 31094897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.
    Patel MR; Worthley SG; Stebbins A; Dill T; Rademakers FE; Valeti US; Barsness GW; Van de Werf F; Hamm CW; Armstrong PW; Granger CB; Kim RJ
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):52-60. PubMed ID: 20129531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiographically Guided Complete Revascularization Versus Selective Stress Echocardiography-Guided Revascularization in Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Disease: The CROSS-AMI Randomized Clinical Trial.
    Calviño-Santos R; Estévez-Loureiro R; Peteiro-Vázquez J; Salgado-Fernández J; Rodríguez-Vilela A; Franco-Gutiérrez R; Bouzas-Mosquera A; Rodríguez-Fernández JÁ; Mesías-Prego A; González-Juanatey C; Aldama-López G; Piñón-Esteban P; Flores-Ríos X; Soler-Martín R; Seoane-Pillado T; Vázquez-González N; Muñiz J; Vázquez-Rodríguez JM
    Circ Cardiovasc Interv; 2019 Oct; 12(10):e007924. PubMed ID: 31554422
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.